Connect with us

Business

ANVISA Authorizes Khiron Life Sciences Corp (OTCMKTS:KHRNF) To Import Medical Cannabis Products Into Brazil From Colombia

Published

on

Brazilian Health Regulatory Agency (ANVISA) has authorized Khiron Life Sciences Corp (OTCMKTS:KHRNF) to import medical cannabis products on an individual patient basis. Khiron can now apply for a license to export medical cannabis products to Brazil with this authorization. The company also needs the nod of TSX for the commercialization of cannabis in Brazil.

Khiron achieves a milestone

Director and Chief Executive Officer of Khiron, Alvaro Torres, said the company achieved another milestone on receiving the regulatory nod from ANVISA to introduce its medical cannabis products in the largest Latin American market. It allows the company to serve the patient population in that region. He further said Khiron work towards achieving authorizations in Peru and Colombia and improves its network in Brazil.

A regulatory framework to import medical cannabis

ANVISA has established a regulatory framework that involves a comprehensive procedure for the production and importing the medical cannabis products into Brazil. The medical cannabis products are prescribed by the physicians and marketed through pharmacies. Therefore, patients get safe access to legal medical cannabis products.  Cannabis is beneficial for regulating oily skin and helps to fight aging.

The market for medical cannabis

The demand for medical cannabis in Brazil expects to reach 1.4 billion in the next three years. Also, the patient base that comprises patients with chronic conditions in Brazil will increase to 3.4 million. The request for medical cannabis products in the nation almost tripled since 2015. Around 1,100 physicians are prescribing medical cannabis products to the patients.

Chairman of Khiron resigns

Sidney Himmel, chairman of Khiron, has resigned to pursue other interests. Following his resignation, Alvaro will act as interim chairman of the company. Deborah Rosati will head the audit committee.

Khiron formed a JV with Dixie Brands to focus on the development of cannabis products. As per the terms of the pact, Dixie will also engage in the manufacture and distribution of kuida brand CBD cosmeceuticals targeting Hispanic population in the US. The joint venture with Dixie Brands gives Khiron exposure to the US market.

Chris Naprawa is a president at Khiron. Before joining Khiron, he worked as MD at Primary Capital and as a partner at Sprott Capital Partners.

*Past performance is not a predictor of future results. All investing involves risk of loss and individual investments may vary. The examples provided may not be representative of typical results. Your capital is at risk when you invest – you can lose some or all of your money. Never risk more than you can afford to lose.By submitting your information you agree to the terms of our Privacy Policy • Cancel Newsletter Any Time.This is a FREE service from Finacials Trend. Signing up for our FREE daily e-letter also entitles you to receive this report. We will NOT share your email address with anyone.

FEATURED STORIES

Business2 days ago

Business intelligence from Akerna Corp (NASDAQ:KERN) Says Liquor Sales are Up 10% Year-over-Year

Post Views: 364 Liquor sales are up 10% year-over-year according to business intelligence from Akerna Corp (NASDAQ:KERN). Red wine took...

Business2 days ago

Pyxis Tankers Inc. (NASDAQ:PXS) Announce Q1 2020 Financial Results Amid COVID-19 Uncertainties

Post Views: 205 Pyxis tankers Inc. (NASDAQ:PXS) has announced its unaudited financial results for the quarter that ended March 31,...

Business2 days ago

Innovative Industrial Properties Inc (NYSE:IIPR) Enters Into a Lease Amendment Agreement with Green Leaf

Post Views: 226 With pot being legalized in many countries, the market is likely to get even bigger. As a...

Business2 days ago

Liberty Leaf Holdings Ltd (OTCMKTS:LIBFD) Takes Over Nova Mentis Biotech Corp And Add Synergies To Its Cannabis Assets In The Wellness And Health Sector

Post Views: 230 Liberty Leaf Holdings Ltd (OTCMKTS:LIBFD) gained access to the psilocybin by acquiring Nova Mentis Biotech Corp. The...

Business3 days ago

Aleafia Health Inc (OTCMKTS:ALEAF) Begins Cultivation At Its Entire Niagara Facility And Provides Consistent Supplies for Health: Settles Disputes With Aphria

Post Views: 341 Aleafia Health Inc (OTCMKTS:ALEAF) will commence cultivation operations at its whole Niagara facility. It obtained a license...

Business3 days ago

Pure Capital Calls For Shareholders Meeting of Therapix Biosciences Ltd (NASDAQ:TRPX): Demands For Dismissal Of Board Members

Post Views: 274 Pure Capital called for an emergency meeting of investors of Therapix Biosciences Ltd (NASDAQ:TRPX) to discuss actions...